Simplex Trading
COGT icon

Simplex Trading’s Cogent Biosciences COGT Stock Holding History

Simplex Trading’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Sell
277
-2,876
-91% -$101K ﹤0.01% 7646
2026
Q1 		$121K Buy
+3,153
New +$116K ﹤0.01% 4859
2025
Q4 		– Sell
-66,988
Closed -$1.88M – 8745
2025
Q3 		$961K Sell
66,988
-12,373
-16% -$147K ﹤0.01% 3090
2025
Q2 		$569K Buy
79,361
+79,349
+661,242% +$440K ﹤0.01% 3365
2025
Q1 		$0 Sell
12
-46,598
-100% -$365K ﹤0.01% 8646
2024
Q4 		$363K Buy
+46,610
New +$465K ﹤0.01% 3864
2024
Q2 		– Sell
-7,303
Closed -$55.4K – 8913
2024
Q1 		$49K Buy
+7,303
New +$45.1K ﹤0.01% 6272
2023
Q4 		– Sell
-2,629
Closed -$20.1K – 8901
2023
Q3 		$25K Buy
+2,629
New +$31.2K ﹤0.01% 6411
2023
Q2 		– Sell
-679
Closed -$7.79K – 9090
2023
Q1 		$7K Sell
679
-1,250
-65% -$16K ﹤0.01% 7802
2022
Q4 		$22K Sell
1,929
-3,624
-65% -$44.9K ﹤0.01% 6770
2022
Q3 		$82K Buy
+5,553
New +$76.1K ﹤0.01% 5785
2022
Q1 		– Sell
-100
Closed -$696 – 10505
2021
Q4 		$0 Buy
+100
New +$869 ﹤0.01% 10568

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Simplex Trading's COGT Position: Q2 2026 in Review

Simplex Trading reduced its Cogent Biosciences (COGT) stake by 91% in Q2 2026, selling an estimated $101K and leaving 277 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7646.

Simplex Trading first reported a position in COGT in Q4 2021 and has held it in 12 quarters since. The position peaked at $961K in Q3 2025. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Simplex Trading held 277 shares of Cogent Biosciences worth $10.7K as of Q2 2026.
  • Simplex Trading sold 2,876 Cogent Biosciences shares in Q2 2026, an estimated $101K.
  • Cogent Biosciences made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7646 holding.
  • Simplex Trading first reported a position in Cogent Biosciences in Q4 2021 and has held it in 12 quarters since.
  • Simplex Trading's Cogent Biosciences position peaked at $961K in Q3 2025.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.